Drugs / Fresh red blood cell (RBC)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02566577 Comparator | Jul 2013 → Mar 2018 | — | Emory University | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fresh red blood cell (RBC) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02566577 ↗ |
| Route | Intravenous | “will be given as an intravenous infusion via a programmable electronic infusion pump” NCT02566577 ↗ |